FISH Probe Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

The FISH Probe market was valued at USD 895.93 Million in 2025. It is poised to grow at a CAGR of 7.40% during the forecast period of 2026-2035, and reach USD 1.82 billion by 2035. The market growth is driven by the rising prevalence of cancer and genetic disorders, increasing demand for precise molecular diagnostics, and growing adoption in clinical and research settings.

Latest News on the FISH Probe Market (2026)

April 2026: Research Advances Optimize FISH Protocols for Regenerative Biology Applications

As published by Nature, researchers posted optimized hybridization chain reaction fluorescence in situ hybridization protocols on April 14 for use in newt ocular tissue regeneration studies. The work expands split-initiator probe design capabilities and supports broader multiplexed FISH adoption across developmental biology and regenerative medicine, signaling continued demand for advanced probe chemistries across academic and translational research markets.

March 2026: Flow-FISH Assay Shows Promise for Detecting Progressive Cervical Precancer

A study covered by the National Library of Medicine described a multi-locus Flow-FISH assay developed at the University of Delhi for cervical precancer stratification. Researchers demonstrated simultaneous detection of STAT3 and HPV16 E6E7 transcripts at single-cell resolution. The finding expands FISH probe applications beyond oncology diagnostics into high-throughput cervical screening, opening new avenues for women's health diagnostic market growth.

Key Market Trends and Insights

• Based on technology, the Flow-FISH segment held approximately 35% in the historical period.
• By probe type, the DNA probes segment accounted for nearly 55% share in the historical period.
• Based on the end use, the clinical diagnostic laboratory segment held around 41% share in the historical period.

Market Size and Forecast

• Market Size (2025) : USD 895.93 Million
• Projected Market Size (2035) : USD 1.82 billion
• CAGR (2026-2035) : 7.40%
• Largest Market in 2025 : North America

FISH Probe Market Overview

FISH Probe technologies are widely utilized in molecular cytogenetics to enable precise detection of chromosomal abnormalities and gene mapping in clinical and research settings. They support advancements in oncology diagnostics, genetic disorder identification, and personalized medicine by offering high sensitivity, specificity, and rapid visualization of genetic alterations. The market was valued at USD 895.93 Million in 2025, reflecting strong adoption and ongoing technological advancements. The growth is further driven by increasing demand for advanced diagnostic tools, rising prevalence of genetic diseases and cancer, and expanding applications in clinical laboratories and research institutions.

FISH Probe Market Segmentation

Market Breakup by Technology

• Q-FISH
• Flow-FISH
• Others

The market is segmented by technology into Q-FISH, Flow-FISH, and others, with growth driven by increasing demand for advanced cytogenetic techniques, high-throughput analysis, and improved accuracy in genetic and chromosomal detection.

Market Breakup by Probe Type

• DNA Probes
• RNA Probes
• mRNA
• miRNA
• Others

The market by probe type is divided into DNA probes, RNA probes, mRNA, miRNA, and others, supported by rising applications in gene expression analysis, molecular diagnostics, and targeted research in oncology and genetic disorders.

Market Breakup by Indication

• Lung Cancer
• Breast Cancer
• Bladder Cancer
• Hematological Malignancies
• Gastric Cancer
• Others

The market include several indications, such as, lung cancer, breast cancer, bladder cancer, hematological malignancies, gastric cancer, and others, driven by the increasing prevalence of cancers and the growing need for precise diagnostic and prognostic tools.

Market Breakup by End Use

• Research Laboratories
• Clinical Diagnostics Laboratories
• Companion Diagnostics

The market is segmented by end use into research laboratories, clinical diagnostics laboratories, and companion diagnostics, fueled by expanding research activities, growing clinical adoption, and the rise of personalized medicine approaches.

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The regions included in the market include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with growth influenced by healthcare infrastructure development, rising investments in diagnostics, and increasing awareness of early disease detection.

Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

WHO projects 35 million cancer cases by 2050, boosting demand for advanced FISH-based diagnostic techniques worldwide.

Market Restraints

High costs, complex procedures, and skilled workforce requirements limit FISH probe adoption, especially in low-income regions.

Many labs avoid FISH testing due to expensive instruments and the need for trained staff, favouring simpler molecular methods.

Market Opportunities

Multiplex imaging advancements enhance RNA and protein detection, expanding FISH applications in research and clinical diagnostics.

Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

FISH Probe Market Growth Drivers

Rising Prevalence of Cancer to Accelerate Market Landscape

The increasing incidence of cancer is a major driver supporting the growth of the market, as demand for precise and early diagnostic tools continues to expand. According to the World Health Organization, over 35 million new cancer cases are projected by 2050, reflecting a 77% increase from 2022, driven by aging populations and rising exposure to risk factors. This trend is expected to boost the adoption of advanced molecular diagnostic techniques, thereby contributing to sustained market growth.

FISH Probe Market Restraints

Elevated Costs and Operational Complexity to Limit Wider Adoption of FISH-Based Diagnostics

The high cost associated with fluorescence in situ hybridization (FISH) probes, instruments, and specialized laboratory infrastructure, along with the need for skilled professionals, significantly restricts market growth. Limited accessibility in low- and middle-income regions and longer processing times compared to alternative molecular techniques further challenge adoption, thereby constraining widespread clinical and research utilization.

FISH Probe Market Opportunities

Innovations in Multiplex Imaging Technologies Enhancing Market Potential

Advancements in multiplex imaging technologies present significant growth opportunities. In January 2025, the launch of HCR™ Gold and HCR™ Pro product lines by Molecular Instruments highlights a major opportunity in advanced multiplex imaging platforms. These innovations enable high-resolution, simultaneous RNA and protein imaging with enhanced sensitivity and preserved morphology, supporting biopharma research and diagnostics. Such advancements are expected to expand applications of FISH technologies, driving future market growth.

FISH Probe Market Trends

The market is witnessing several trends, including rising single-cell genomics adoption and the expansion of companion diagnostics in oncology applications.

Growing Advancement in Single-Cell Genomic Analysis Technologies is Likely to Elevate Market Growth

The market is experiencing strong growth due to advancements in single-cell genomics analysis technologies that enhance precision and sensitivity in detecting chromosomal abnormalities. In March 2023, KromaTiD launched its dGH in-Site™ CAR-T Kit, enabling high-resolution detection of structural variants in T-cell engineering. This development supports improved genomic profiling in research and cell therapy, driving the adoption of advanced fluorescence in-situ hybridization solutions and significantly contributing to market growth.

Rising Integration of Companion Diagnostics to Boost the FISH Probe Market Value

The increasing advancement of companion diagnostics in the market is strengthening its role in precision oncology. In September 2024, Amoy Diagnostics Co., Ltd. received approval in Japan for its FGFR2 Break-apart FISH Probe Kit used with Eisai’s Tasurgratinib for biliary tract cancer. This integration of FISH technology in targeted therapy selection enhances treatment accuracy and is significantly boosting overall market value.

FISH Probe Market Share

Lung Cancer Indication Segment is Likely to Lead the Market Share by Indication

The market is segmented by indication into lung cancer, breast cancer, bladder cancer, hematological malignancies, gastric cancer, and others, with lung cancer expected to lead the market. This dominance is driven by its high global burden; according to World Health Organization, 2.5 million new cases and 1.8 million deaths were recorded in 2022, largely linked to tobacco smoking, air pollution, and occupational exposure, supporting strong diagnostic demand.

FISH Probe Market Analysis by Region

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is expected to lead the market, supported by advanced healthcare infrastructure, strong adoption of molecular diagnostics, and ongoing technological innovations. For instance, in March 2025, Vitro appointed Biocare Medical as the exclusive U.S. distributor for its NeoPATH Pro instrument, strengthening access to high-throughput FISH-enabled diagnostic platforms. This development is expected to further enhance regional leadership in cancer diagnostics and precision medicine applications.

Leading Players in the FISH Probe Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc. is a global life sciences company specializing in advanced analytical and molecular diagnostic solutions. It offers Fluorescence In Situ Hybridization (FISH) and RNA FISH ViewRNA assays, including FISH Tag detection kits and SuperBoost signal amplification systems. The company actively contributes to the market by enabling high sensitivity, multiplex genetic analysis and supporting cancer research and clinical diagnostics worldwide.

BioDot, Inc.

BioDot, Inc. develops automated laboratory solutions for fluorescence in situ hybridization (FISH) workflows, including its CellWriter™ platform and FISHArray™ slides. These technologies reduce probe usage, enable multiplex assays, and improve efficiency through automation and on-chip processing. The company supports the market by enhancing diagnostic accuracy and laboratory productivity in clinical and research settings.

Agilent Technologies, Inc.

Agilent Technologies, Inc. is a global life sciences and diagnostics company involved in advanced molecular and genomic solutions. Its SureFISH DNA FISH probes are designed using oligonucleotide-based synthesis technology, enabling high specificity and accuracy in detecting genetic abnormalities. The company plays a key role in the FISH probe market by supporting cancer diagnostics and research applications through innovative probe design for precise gene targeting and chromosomal analysis.

Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation is a biotechnology company specializing in gene synthesis and cytogenetics solutions. The company offers fluorescence in situ hybridization (FISH) probes designed for detecting gene amplification, loss, and chromosomal translocations. Its dual-colored, BAC-based probes support precise genetic analysis across various tissue types. Abnova actively contributes to the market by enhancing research and diagnostic capabilities in molecular genetics and oncology.

Other key players in the market are Biosearch Technologies, Inc., Genemed Biotechnologies, Inc., Biocare Medical, LLC, QIAGEN N.V., Bio-Rad Laboratories, Inc., and Oxford Gene Technology IP Limited.

Key Questions Answered in the FISH Probe Market Report

• What was the FISH probe market value in 2025?
• What is the FISH probe market forecast outlook for 2026-2035?
• What major factors aid the demand for the FISH probe market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major FISH probe market trends?
• Which technology is expected to dominate the market segment?
• Which probe type is projected to lead the market segment?
• Which indication is anticipated to drive the market segment?
• Which end use is likely to dominate the market segment?
• Who are the key players in the FISH probe market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?